Skip to main content
AkademIndex

Products

For developers

AkademBaseOpen API for the ecosystem

Aleksandr B. Shek

24 works

Republican Specialized Center of Cardiology Ministry of Health of Uzbekistan

  1. FEATURES OF CORONARY ARTERIES LESION AT UNSTABLE ANGINA PATIENTS DEPENDING ON DISTRIBUTION OF APO С-III GENE POLYMORPHISM AND TYPE OF DISLIPIDEMIA

    A. S. Eshpulatov, Shavkat U. Hoshimov, L. E. Kan +5

    ArticleLipid metabolism and disordersEurasian heart journal20140 citations
    ABI

  2. PERSONALIZED STATIN THERAPY IN IMPROVING THE TREATMENT OF CORONARY ARTERY DISEASE AND ATHEROSCLEROSIS

    Umidakhon Makhmudova, Sh. U. Hoshimov, G. J. Abdullayeva +2

    ArticlePharmacogenetics and Drug MetabolismEurasian heart journal20150 citations
    ABI

  3. Study of main arteries stiffness in patients with coronary heart disease depending on prevalence of atherosclerosis

    Ulugbek Nizamov, F.M. Bekmetova, S. KHOSHIMOV +2

    ArticleCardiovascular Health and Disease PreventionCor et Vasa20160 citations
    ABI

  4. P767Efficacy and safety of switching simvastatin intolerant patients with coronary artery disease to rosuvastatin treatment

    Aleksandr B. Shek, Р. Д. Курбанов, G J Abdullaeva +3

    ArticleLipoproteins and Cardiovascular HealthEuropean Heart Journal20170 citations
    ABI

  5. DISTRIBUTION OF POLYMORPHISMS OF GENES OF STATINS METABOLISM AND TRANSPORT IN THE LIVER IN PATIENTS WITH CORONARY ARTERY DISEASE ETHNIC UZBEKS WITH SIMVASTATIN INTOLERANCE

    Aleksandr B. Shek, R. D. Kurbanov, G. J. Abdullayeva +5

    ArticleLipoproteins and Cardiovascular HealthEurasian heart journal20170 citations
    ABI

  6. Burden of familial heterozygous hypercholesterolemia in Uzbekistan: Time is muscle

    Aleksandr B. Shek, Rano Alieva, R. D. Kurbanov +4

    ArticleLipoproteins and Cardiovascular HealthAtherosclerosis20180 citations
    ABI

  7. Personalized rosuvastatin therapy in problem patients with partial statin intolerance

    Aleksandr B. Shek, R. D. Kurbanov, Rano B. Alieva +5

    ArticleLipoproteins and Cardiovascular HealthArchives of Medical Science - Atherosclerotic Diseases20180 citations
    ABI

  8. Can metformin stabilize PCSK9 level in stable coronary artery disease patients treated with statins?

    Aleksandr B. Shek, Rano B. Alieva, R. D. Kurbanov +3

    ArticleLipoproteins and Cardiovascular HealthArchives of Medical Science - Atherosclerotic Diseases20190 citations
    ABI

  9. ASSOTIATION OF THE GENETIC POLYMORPHISM E670G OF THE PCSK-9 AND THE SEVERITY OF THE CAROTID ATHEROSCLEROSIS IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN UZBEK POPULATION

    Rano B. Alieva, Shavkat U. Hoshimov, Sh. S. Ahmedova +3

    ArticleLipoproteins and Cardiovascular HealthEurasian heart journal20190 citations
    ABI

  10. Structural Changes Brachiocephalic Arteries In Patients With Chd And Hefh Taking Into Account The Level Of Pcsk9 And Genetic Polymorphism E670G Of The Pcsk9 Gene

    Р Алиева, Aleksandr B. Shek, Р. Д. Курбанов +2

    ArticleCancer, Lipids, and MetabolismAtherosclerosis20190 citations
    ABI

  11. Influence of MMP-3 genetic polymorphism on arterial stuffness in patients with coronary heart disease

    Р Алиева, Ulugbek Nizamov, S N Akhmedova +1

    ArticleCardiovascular Health and Disease PreventionAtherosclerosis20200 citations
    ABI

  12. The value of the Left Ventricular Emission Fraction in Patients with Ischaemic Heart Disease with Diabetes Mellitus 2 in the Assessment of the Effectiveness of Sitagliptin/Metformin

    Раиса Тригулова, Dilnoza Alimova, N.F. Tashkenbaeva +4

    ArticleDiabetes Treatment and ManagementAmerican Heart Journal20210 citations
    ABI

  13. The Relationship Between Glycemia and Heart Failure in Patients with Coronary Heart Disease and Diabetes Mellitus 2

    Раиса Тригулова, N.F. Tashkenbaeva, F.M. Bekmetova +4

    ArticleCardiovascular Function and Risk FactorsAmerican Heart Journal20210 citations
    ABI

  14. Gender Differences in 10-Year Mortality in Patients with Coronary Artery Disease with Elevated Lipoprotein(a): In Search of Invisible Guardian Angel

    Aleksandr B. Shek, Rano B. Alieva, А. А. Абдуллаев +5

    ArticleLipoproteins and Cardiovascular HealthInternational Journal of Biomedicine20220 citations
    ABI

  15. Polymorphism in the apolipoprotein C3 gene and coronary lesions in patients with CHD

    Р Алиева, A. Eshpulatov, Aleksandr B. Shek

    ArticleLipoproteins and Cardiovascular HealthAtherosclerosis20220 citations
    ABI

  16. Effect of combined carriage of polymorphic markers ApoE (Ε2/Ε3/Ε4) and ApoA1 (G-75A) on the ApoB/ApoA-I ratio in CAD patients in the Uzbek population

    Р Алиева, Aleksandr B. Shek, А. А. Абдуллаев +4

    ArticleAntiplatelet Therapy and Cardiovascular DiseasesAtherosclerosis20230 citations
    ABI

  17. Assessment of the distribution of PCSK9 E670G genetic polymorphism in patients with heterozygous familial hypercholesterolemia depending on the presence of diabetes mellitus

    Р Алиева, Aleksandr B. Shek, А. А. Абдуллаев +5

    ArticleLipoproteins and Cardiovascular HealthAtherosclerosis20230 citations
    ABI

  18. Relationship of blood lipid spectrum indicators with coronary calcinosis due to statin treatment in patients with high cardiovascular risk

    Rano B. Alieva, Bernara Kurbanova, Shokhista Akhmedova +4

    ArticleBiomarkers in Disease MechanismsAtherosclerosis20240 citations
    ABI

  19. Prospects for the Use of Personalized Therapy in Patients with Coronary Heart Disease and Heterozygous FH against the Background of Diabetes Mellitus

    Rano Alieva, Aleksandr B. Shek, Alisher Abdullaev +7

    ChapterLipoproteins and Cardiovascular Health20240 citations
    ABI

  20. Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry

    Amany Elshorbagy, Antonio J. Vallejo‐Vaz, Fotios Barkas +80

    ArticleLipoproteins and Cardiovascular HealthEuropean Heart Journal20250 citations
    ABI

  21. Comparative analysis of cardiometabolic parameters in patients with coronary heart disease with and without non-alcoholic fatty liver disease

    D. B. Yusupalieva, Р Алиева, Ulugbek Nizamov +4

    ArticleLiver Disease Diagnosis and TreatmentExploration of Cardiology20250 citations
    ABI

  22. The impact of one-year inclisiran treatment on achieving target low-density lipoprotein cholesterol levels in patients with chronic coronary syndrome

    Rano B. Alieva, Aleksandr B. Shek, Khurshid Fozilov +3

    ArticleLipoproteins and Cardiovascular HealthAtherosclerosis20250 citations
    ABI

  23. Global survey of genetic testing methods for familial hypercholesterolaemia: a study and recommendations from the European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration registry

    Joana Rita Chora, Irene Karungi, Amany Elshorbagy +70

    ArticleLipoproteins and Cardiovascular HealthEuropean Journal of Preventive Cardiology20260 citations
    ABI

  24. Lipid clinics worldwide: harmonization and guidance on how to optimally organize and fund. European Atherosclerosis Society consensus statement across 55 countries and more than 500 lipid clinics

    Christian Bork, Børge G. Nordestgaard, Berit Storgaard Hedegaard +67

    ArticleLipoproteins and Cardiovascular HealthAtherosclerosis20260 citations
    ABI